A pharmacokinetic-pharmacodynamic model of chemotherapy of human immunodeficiency virus infection that relates development of drug resistance to treatment intensity.
- 1 January 1997
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 25 (6) , 713-730
- https://doi.org/10.1023/a:1025781801322
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Faculty Opinions recommendation of Mutations of Bacteria from Virus Sensitivity to Virus Resistance.Published by H1 Connect ,2010
- Development of Drug Resistance to HIV-1 Protease InhibitorsJournal of Biological Chemistry, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Viral QuasispeciesScientific American, 1993
- Coexistence and competition in HIV infectionsJournal of Theoretical Biology, 1992
- Antigenic Diversity Thresholds and the Development of AIDSScience, 1991
- Population dynamics of HIV within an individual after treatment with zidovudineAIDS, 1991
- Molecular Pharmacologic Approaches to the Treatment of AidsAnnual Review of Pharmacology and Toxicology, 1988
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984